Provenienza dei contatti di primo grado di Kenji Ueno
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kenji Ueno tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
NEC CORPORATION | Information Technology Services | Chairman | |
Boston Biomedical, Inc.
Boston Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sumitomo Chemical Co., Ltd., Boston Biomedical, Inc. is a developer of novel cancer therapeutics with the goal of significantly improving patient outcomes. The private company is based in Norwood, MA. The company's most advanced research programs are focused on investigational agents that inhibit multiple oncogenic pathways, including cancer stemness pathways, and modifying immune responses. The company was founded by Chiang J. Li. Boston Biomedical was acquired by Sumitomo Pharma Co., Ltd. on April 25, 2012 for $2,630 million. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Tolero Pharmaceuticals, Inc.
Tolero Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Tolero Pharmaceuticals, Inc. manufactures and markets pharmaceutical products. It is a clinical-stage biopharmaceutical company with a single-minded purpose to alleviate human suffering through the development of medicines to treat cancer and other serious human diseases. The company is headquartered in Lehi, UT. | Pharmaceuticals: Other | Director/Board Member | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
TOKIO MARINE HOLDINGS, INC. | Property/Casualty Insurance | Director/Board Member | |
IHI CORPORATION | Industrial Machinery | Director/Board Member | |
SEIKO GROUP CORPORATION | Other Consumer Specialties | Director/Board Member | |
JCR PHARMACEUTICALS CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
SEIKO EPSON CORPORATION | Computer Peripherals | Chairman | |
University of Tokyo | College/University | Undergraduate Degree | |
Tokyo Institute of Technology | College/University | Doctorate Degree | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
Hiroshima University | College/University | Doctorate Degree | |
JAPAN POST INSURANCE CO., LTD. | Life/Health Insurance | Director/Board Member | |
Nihon Medi-Physics Co., Ltd.
Nihon Medi-Physics Co., Ltd. Pharmaceuticals: MajorHealth Technology Nihon Medi-Physics Co., Ltd. is a leading manufacturer of radiopharmaceuticals, based in Japan. The Japanese company is engaged in ensuring stable supply and research and development of new products. It is also working on research and development of "theranostics," a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. Nihon Medi-Physics Co. was founded in 1973, and the CEO is Nobuhiko Tamura. | Pharmaceuticals: Major | Chief Executive Officer | |
NEC Asia Pacific Pte Ltd.
NEC Asia Pacific Pte Ltd. Information Technology ServicesTechnology Services NEC Asia Pacific Pte Ltd. provides computer software solutions. Its solutions and services include digital signage, ERP, infrastructure, managed services and outsourcing, RFID, public safety solutions and services, unified communications and virtual PC center. The company was founded in 1977 and is headquartered in Singapore. | Information Technology Services | Chairman | |
RENESAS ELECTRONICS CORPORATION | Semiconductors | Director/Board Member | |
Financial Services Agency | General Government | Corporate Officer/Principal | |
Sumitomo Pharma Animal Health Co., Ltd.
Sumitomo Pharma Animal Health Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Sumitomo Pharma Animal Health Co., Ltd. is a Japanese company that manufactures and supplies pharmaceuticals, food ingredients, food additives, veterinary medicines, and diagnostics. The private company is based in Osaka, Japan and was founded in 2010. | Pharmaceuticals: Major | Chief Executive Officer | |
JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
Primetals Technologies Ltd.
Primetals Technologies Ltd. Information Technology ServicesTechnology Services Primetals Technologies Ltd. operates as a engineering and plant construction company. It manures of steel and iron products. The company was founded in January 2015 and is headquartered in London, the United Kingdom. | Information Technology Services | Director of Finance/CFO | |
Sunovion Pharmaceuticals Europe Ltd.
Sunovion Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Sunovion Pharmaceuticals Europe Ltd. is a British European pharmaceutical company founded in 2013 that is dedicated to improving the lives of patients through the supply of essential medicines. The company is based in London, UK. The company commercializes and distributes a portfolio of specialty brands and hospital products in 40 countries worldwide, both directly and through strategic partnerships. The company's vision is to become a recognized partner of choice through their commercial excellence, patient focus, and presence across the globe. Sunovion Pharmaceuticals Europe aims to have a positive impact on society through their pioneering focus on their environment, social, and governance (ESG) goals. | Pharmaceuticals: Major | Chief Executive Officer | |
Meltin MMI KK
Meltin MMI KK Medical SpecialtiesHealth Technology Meltin MMI KK develops bio-signal interface technologies. It offers biosignal processing and cable-driven ststems. The company was founded by Sumio Ito, Masahoro Kasuya and Tatsuya Seki and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member | |
UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member | |
Pancreas Research Foundation of Japan | Chairman | ||
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
TOKYU FUDOSAN HOLDINGS CORPORATION | Real Estate Development | Director/Board Member |
Statistiche
Distribuzione geografica
Giappone | 21 |
Stati Uniti | 9 |
Regno Unito | 4 |
Bermuda | 3 |
Singapore | 2 |
Settori
Health Technology | 16 |
Finance | 6 |
Technology Services | 4 |
Electronic Technology | 4 |
Consumer Services | 4 |
Posizioni
Director/Board Member | 46 |
Corporate Officer/Principal | 20 |
Independent Dir/Board Member | 11 |
Chairman | 8 |
President | 7 |
Contatti più connessi
- Borsa valori
- Insiders
- Kenji Ueno
- Connessioni Società